DJIA 16,258.55 200.20 1.25%
NASDAQ 4,700.40 64.29 1.39%
S&P 500 1,933.72 19.87 1.04%
market minute promo

230.13 6.08 (2.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $230.13 2.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $225.73
Previous Close $224.05
Daily Range $222.43 - $229.70
52-Week Range $111.41 - $263.81
Market Cap $78.9B
P/E Ratio 92.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,067,534
Average Daily Volume 2,001,302
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary

Why Valeant Splurged $1 Billion on Sprout... and Why It's Worth It

The acquisitive pharmaceutical giant grabs the maker of the "female Viagra."

Baffling Valeant Strikes For Troubled Astra Psoriasis Project

Midday Update: U.S. Markets Starting to Retrace Earlier Advance But Gains Slowed By Losses For Energ

Midday Update: U.S. Markets Starting to Retrace Earlier Advance But Gains Slowed By Losses For Energy Stocks

Stocks Hitting 52-Week Highs

Valeant Pharmaceuticals (VRX) Stock Climbs on Synergetics Deal

Valeant Pharmaceuticals To Acquire Synergetics USA, $6.50/Share

Bristol-Myers to Pay up to $1.25B for Right to Buy Promedior

US Stock Futures Tumble Ahead Of Economic Data

Valeant, AstraZeneca to Partner on Brodalumab; Valeant to Make Upfront Payment to AstraZeneca of $10

Valeant, AstraZeneca to Partner on Brodalumab; Valeant to Make Upfront Payment to AstraZeneca of $100M; Up to $345M in Milestone Payments

Novogen (NVGN) Conducts Scientific Review of R&D Program

See More VRX News...

VRX's Top Competitors

VRX $230.13 (2.71%)
Current stock: VRX
JNJ $93.30 (1.31%)
Current stock: JNJ
NVS $95.28 (0.63%)
Current stock: NVS
RHHBY $33.22 (-0.46%)
Current stock: RHHBY